Phase 2 study of safety and efficacy of a transanal tube (WING DRAIN) for the prevention of anastomotic leakage after rectal cancer surgery.

Phase 2 study of safety and efficacy of a transanal tube (WING DRAIN) for the prevention of anastomotic leakage after rectal cancer surgery. - WING DRAIN Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027455

Enrollment

120

Registered

2017-07-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

We placed transanal tube:WING DRAIN at low anterior resection surgery, and removed it at 4 or 5 postoperative days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Rectal cancer is located at within 10cm above the anal verge 2. Histologically proven rectal adenocarcinoma on biopsy 3. Initial operation for rectal cancer excluding local excision 4. The patients undergoing low anterior resection with mechanical anastomosis 5. The patients have no ileus preoperatively. 6. Organ function is preserved 7. Patient with ECOG performance status of 0, 1, or 2 8. Written informed consent to participation in this trial

Exclusion criteria

Exclusion criteria: 1. Emergency operation 2. Other conditions judged ineligible by physician

Design outcomes

Primary

Measure	Time frame
Symptomatic leakage rate	—

Secondary

Measure	Time frame
Symptomatic leakage rate and Radiological leakage rate Complication rate connected with WING DRAIN	—

Countries

Japan

Contacts

Public ContactYuji Nishizawa

National Cancer Center Hospital East Colorectal Surgery

yunishiz@east.ncc.go.jp+81-4-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026